The rise of weight-loss drugs like Ozempic is reshaping the 21st century, with profound impacts on health care, the economy, and social norms. From potentially slashing obesity-related health costs by billions to altering food consumption habits and extending healthy lifespans, these medications are disrupting industries and behaviors. This presentation will explore the ripple effects on brands, consumer choices, relationships, and societal dynamics, highlighting the winners, losers, and the far-reaching implications of this groundbreaking shift.